Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome, and immune responses in colitis.

While conventional approaches for inflammatory bowel diseases (IBD) mainly focus on suppressing hyperactive immune responses, it remains unclear how to address disrupted intestinal barriers, dysbiosis of the gut commensal microbiota, and dysregulated mucosal immune responses in IBD. Moreover, immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yonghyun, Sugihara, Kohei, Gillilland, Merritt G., Jon, Sangyong, Kamada, Nobuhiko, Moon, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923573/
https://www.ncbi.nlm.nih.gov/pubmed/31427744
http://dx.doi.org/10.1038/s41563-019-0462-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923573/
https://www.ncbi.nlm.nih.gov/pubmed/31427744
http://dx.doi.org/10.1038/s41563-019-0462-9

Ejemplares similares